Our portfolio consists of Amdipharm, Mercury and BNM Group products in both Australia and New Zealand. All products under the Amdipharm and Mercury banner are owned by ADVANZ PHARMA with the majority of the BNM Group products both in Australia and New Zealand being in licensed.
A strong focus on sole supply off patent pharmaceuticals together with an innovative range of anaesthesia and critical care hospital injectable products. BNM works in partnership with a number of businesses, including multinational pharmaceutical companies.
A direct tender-based business with Pharmac covering hospital injectables, oral pharmaceuticals and complementary medicines together with our partner based in New Zealand, AFT Pharmaceuticals Ltd.